INS and obesity due to melanocortin 4 receptor deficiency: Interestingly, glutamine treatment can ameliorate obesity and related comorbidities in mice (Figure 5), consistent with previous observations that glutamine supplementation reduces obesity with an improvement in systemic insulin action 70,71.